Agati J M, Yeagley D, Quinn P G
Department of Cellular and Molecular Physiology, The Pennsylvania State University, College of Medicine, Hershey, Pennsylvania 17033, USA.
J Biol Chem. 1998 Jul 24;273(30):18751-9. doi: 10.1074/jbc.273.30.18751.
Transcription of the phosphoenolpyruvate carboxykinase (PEPCK) gene is induced by glucagon, acting through cAMP and protein kinase A, and this induction is inhibited by insulin. Conflicting reports have suggested that insulin inhibits induction by cAMP by activating the Ras/mitogen-activated protein kinase (MAPK) pathway or by activating the phosphatidylinositol 3-kinase (PI3-kinase), but not MAPK, pathway. Insulin activated PI3-kinase phosphorylates lipids that activate protein kinase B (PKB) and Ca2+/diacylglycerol-insensitive forms of protein kinase C (PKC). We have assessed the roles of these pathways in insulin inhibition of cAMP/PKA-induced transcription of PEPCK by using dominant negative and dominant active forms of regulatory enzymes in the Ras/MAPK and PKB pathways and chemical inhibitors of PKC isoforms. Three independently acting inhibitory enzymes of the Ras/MAPK pathway, blocking SOS, Ras, and MAPK, had no effect upon insulin inhibition. However, dominant active Ras prevented induction of PEPCK and also stimulated transcription mediated by Elk, a MAPK target. Insulin did not stimulate Elk-mediated transcription, indicating that insulin did not functionally activate the Ras/MAPK pathway. Inhibitors of PI3-kinase, LY294002 and wortmannin, abolished insulin inhibition of PEPCK gene transcription. However, inhibitors of PKC and mutated forms of PKB, both of which are known downstream targets of PI3-kinase, had no effect upon insulin inhibition. Dominant negative forms of PKB did not interfere with insulin inhibition and a dominant active form of PKB did not prevent induction by PKA. Phorbol ester-mediated inhibition of PEPCK transcription was blocked by bisindole maleimide and by staurosporine, but insulin-mediated inhibition was unaffected. Thus, insulin inhibition of PKA-induced PEPCK expression does not require MAPK activation but does require activation of PI3-kinase, although this signal is not transmitted through the PKB or PKC pathways.
磷酸烯醇式丙酮酸羧激酶(PEPCK)基因的转录由胰高血糖素诱导,通过环磷酸腺苷(cAMP)和蛋白激酶A发挥作用,而这种诱导作用会被胰岛素抑制。相互矛盾的报道表明,胰岛素通过激活Ras/丝裂原活化蛋白激酶(MAPK)途径或通过激活磷脂酰肌醇3激酶(PI3激酶)(而非MAPK途径)来抑制cAMP的诱导作用。胰岛素激活的PI3激酶使脂质磷酸化,从而激活蛋白激酶B(PKB)以及对Ca2+/二酰基甘油不敏感的蛋白激酶C(PKC)形式。我们通过使用Ras/MAPK和PKB途径中调节酶的显性负性和显性活性形式以及PKC亚型的化学抑制剂,评估了这些途径在胰岛素抑制cAMP/PKA诱导的PEPCK转录中的作用。Ras/MAPK途径的三种独立作用的抑制酶,分别阻断SOS、Ras和MAPK,对胰岛素抑制作用没有影响。然而,显性活性Ras阻止了PEPCK的诱导,并且还刺激了由MAPK靶点Elk介导的转录。胰岛素并未刺激Elk介导的转录,这表明胰岛素在功能上并未激活Ras/MAPK途径。PI3激酶抑制剂LY294002和渥曼青霉素消除了胰岛素对PEPCK基因转录的抑制作用。然而,PKC抑制剂以及PKB的突变形式(二者均为已知的PI3激酶下游靶点)对胰岛素抑制作用没有影响。显性负性形式的PKB不干扰胰岛素抑制作用,而显性活性形式的PKB也不能阻止PKA的诱导作用。佛波酯介导的PEPCK转录抑制被双吲哚马来酰胺和星形孢菌素阻断,但胰岛素介导的抑制作用不受影响。因此,胰岛素对PKA诱导的PEPCK表达的抑制作用不需要MAPK激活,但确实需要PI3激酶激活,尽管该信号并非通过PKB或PKC途径传递。